文献速递肿瘤 PET/CT甲状腺核医学

共存转移性甲状腺乳头状癌与前列腺癌在18F-氟环丁氨酸和68Ga-PSMA-11 PET/CT上的影像特征

Imaging Characteristics of Coexisting Metastatic Papillary Thyroid Cancer and Prostate Cancer on 18 F-Fluciclovine and 68 Ga-PSMA-11 PET/CT.
PubMed 文献 · Clin Nucl Med · 2022-03-30

一例76岁男性,有转移性甲状腺乳头状癌(纵隔结节)和前列腺癌(前列腺切除及雄激素剥夺治疗)病史。18F-氟环丁氨酸PET显示纵隔结节和L5硬化灶摄取增高,当时PSA为0.4 ng/mL,L5活检证实为前列腺癌转移。2个月后68Ga-PSMA-11 PET显示L5转移灶摄取增高,但纵隔结节无摄取。患者接受L5病灶放疗后反应良好。

要点

  • 18F-氟环丁氨酸PET对甲状腺癌纵隔转移和前列腺癌L5转移均显示摄取增高。
  • 68Ga-PSMA-11 PET仅显示L5前列腺癌转移摄取增高,纵隔甲状腺癌转移无摄取。
  • L5病灶活检证实为前列腺癌转移,放疗后反应良好。

核心结论

  • 18F-氟环丁氨酸PET可显示甲状腺癌和前列腺癌转移灶摄取,而68Ga-PSMA-11 PET仅显示前列腺癌转移灶摄取。

研究设计与样本

  • 本文为病例报告,描述一例76岁男性患者的影像学检查及临床经过。

主要发现

  • 18F-氟环丁氨酸PET显示纵隔结节和L5硬化灶摄取增高,当时前列腺特异性抗原水平为0.4 ng/mL。
  • L5病灶活检证实为前列腺癌转移。
  • 68Ga-PSMA-11 PET(2个月后)显示L5转移灶摄取增高,纵隔结节无摄取。
  • 患者接受L5病灶放疗后反应良好。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 76-year-old man with biopsy-proven metastatic papillary thyroid cancer in a mediastinal nodule status post total thyroidectomy is on surveillance. The patient also had prostate cancer and received prostatectomy and androgen deprivation treatment. An 18 F-fluciclovine PET revealed avid lesions in the mediastinal nodule and a sclerotic focus at L5 with concurrent prostate-specific antigen level of 0.4 ng/mL. The L5 lesion was later biopsied and confirmed as metastasis from prostate cancer. A 68 Ga-PSMA-11 PET 2 months later showed avid radiotracer uptake within L5 metastasis but not the mediastinal nodule. The patient received radiation therapy to the L5 lesion and responded well.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Lu Y. Imaging Characteristics of Coexisting Metastatic Papillary Thyroid Cancer and Prostate Cancer on 18 F-Fluciclovine and 68 Ga-PSMA-11 PET/CT. Clin Nucl Med. 2022. PMID: 35353761. doi:10.1097/RLU.0000000000004156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。